AimTo evaluate use of palliative care services in patients with end-stage liver disease who do not have access to liver transplant.MethodsEvaluated were end-stage liver disease patients who were removed from the liver transplant wait-list or died prior to transplant at a single transplant center over a 2-year period. Those who were removed due to noncompliance or ultimately transplanted elsewhere were excluded from this study. Patient characteristics associated with palliative care consultation were assessed using logistic regression analysis.ResultsSix hundred and eighty-three patients were listed for liver transplant in 2013-2014 with 107 (16%) dying (n = 62) or removed for clinical decompensation prior to liver transplant (n = 45): Media...
Individuals with decompensated cirrhosis (DC) in the United States (U.S.) receive costly, burdensome...
Living-donor liver transplant (LDLT) offers advantages over deceased-donor liver transplant (DDLT) o...
Background: End-stage liver disease (ESLD) patients carry heavy symptom burdens and risk receiving a...
Introduction and Aim: Utilization of palliative care services in patients dying of end-stage liver d...
Background & aimsThere has been increased attention on ways to improve the quality of end-of-lif...
Background and Aims: End-stage liver disease (ESLD) is an important cause of morbidity and mortality...
Background/aimPalliative care services (PCS) are recommended to enhance quality of care for hospital...
Background: Palliative care (PC) and hospice care are underutilized for patients with end-stage live...
Introduction: End-stage liver disease (ESLD) is the advanced phase of most liver diseases. The cure ...
Problem: Patients with end-stage liver disease (ESLD) have high mortality, symptom burden, and healt...
ContextAlthough palliative care (PC) has been shown to improve symptoms and end-of-life (EOL) care f...
ABSTRACT This article aims to review the importance of palliative care medicine in patients undergoi...
Despite the likely benefits of palliative care (PC) for patients with cirrhosis, physician experienc...
Background: Prevention of death in patients on the waiting list for liver transplantation (LT) is a ...
The mortality rate from chronic liver disease in the UK is rising rapidly, and patients with advance...
Individuals with decompensated cirrhosis (DC) in the United States (U.S.) receive costly, burdensome...
Living-donor liver transplant (LDLT) offers advantages over deceased-donor liver transplant (DDLT) o...
Background: End-stage liver disease (ESLD) patients carry heavy symptom burdens and risk receiving a...
Introduction and Aim: Utilization of palliative care services in patients dying of end-stage liver d...
Background & aimsThere has been increased attention on ways to improve the quality of end-of-lif...
Background and Aims: End-stage liver disease (ESLD) is an important cause of morbidity and mortality...
Background/aimPalliative care services (PCS) are recommended to enhance quality of care for hospital...
Background: Palliative care (PC) and hospice care are underutilized for patients with end-stage live...
Introduction: End-stage liver disease (ESLD) is the advanced phase of most liver diseases. The cure ...
Problem: Patients with end-stage liver disease (ESLD) have high mortality, symptom burden, and healt...
ContextAlthough palliative care (PC) has been shown to improve symptoms and end-of-life (EOL) care f...
ABSTRACT This article aims to review the importance of palliative care medicine in patients undergoi...
Despite the likely benefits of palliative care (PC) for patients with cirrhosis, physician experienc...
Background: Prevention of death in patients on the waiting list for liver transplantation (LT) is a ...
The mortality rate from chronic liver disease in the UK is rising rapidly, and patients with advance...
Individuals with decompensated cirrhosis (DC) in the United States (U.S.) receive costly, burdensome...
Living-donor liver transplant (LDLT) offers advantages over deceased-donor liver transplant (DDLT) o...
Background: End-stage liver disease (ESLD) patients carry heavy symptom burdens and risk receiving a...